Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2015 Oct 22;231(2):288–294. doi: 10.1002/jcp.25098

Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases

Stewart Siyan Cao 1,, Katherine L Luo 1, Lynn Shi 1
PMCID: PMC4659393  NIHMSID: NIHMS737237  PMID: 26201832

Abstract

The endoplasmic reticulum (ER) is a critical organelle for normal cell function and homeostasis. Disturbance in the protein folding process in the ER, termed ER stress, leads to the activation of unfolded protein response (UPR) that encompasses a complex network of intracellular signaling pathways. The UPR can either restore ER homeostasis or activate pro‐apoptotic pathways depending on the type of insults, intensity and duration of the stress, and cell types. ER stress and the UPR have recently been linked to inflammation in a variety of human pathologies including autoimmune, infectious, neurodegenerative, and metabolic disorders. In the cell, ER stress and inflammatory signaling share extensive regulators and effectors in a broad spectrum of biological processes. In spite of different etiologies, the two signaling pathways have been shown to form a vicious cycle in exacerbating cellular dysfunction and causing apoptosis in many cells and tissues. However, the interaction between ER stress and inflammation in many of these diseases remains poorly understood. Further understanding of the biochemistry, cell biology, and physiology may enable the development of novel therapies that spontaneously target these pathogenic pathways. J. Cell. Physiol. 231: 288–294, 2016. © 2015 Wiley Periodicals, Inc.


The endoplasmic reticulum (ER) is a membrane‐bound organelle that plays a crucial role in many cellular processes, in particular, the folding and trafficking of secretory and membrane proteins, lipid and carbohydrate metabolism, and detoxification. ER protein folding and transport are highly sensitive to any disturbance in ER homeostasis. One such disturbance, termed ER stress, involves the accumulation of unfolded and misfolded proteins, and activates the unfolded protein response (UPR), which recruits downstream signaling pathways to restore ER homeostasis. In the presence of ER stress in mammalian cells, UPR is activated via three branches of signaling pathways, each involving a protein sensor on the ER membrane: inositol‐requiring kinase 1 α (IRE1α), pancreatic ER eIF2α kinase (PERK), and activating transcription factor 6 α (ATF6α). In the absence of ER stress, ER luminal‐binding protein chaperone BiP/GRP78 maintains the inactive states of these three pathways by binding to the luminal domains of these sensors and prevents their activation. In ER stress, BiP dissociates from the luminal domains, thereby activating these three branches of UPR (Cao and Kaufman, 2012; Hetz, 2012).

The most conserved signaling branch of UPR involves IRE1, a type I transmembrane protein with both a Ser/Thr kinase domain and an endoribonuclease (RNase) domain in its cystolic portion. Upon release from BiP inhibition, the luminal domain of IRE1α undergoes homo‐oligomerization and trans‐autophosphorylation, and initiates its kinase and RNase activities. The endoribonuclease activity of IRE1α cleaves and removes a 26 base intron from the mRNA of the X‐box‐binding protein‐1 (XBP1) and produces a translational frame‐shift that produces the active CREB/ATF base leucine zipper‐containing (bZIP) transcriptional factor XBP1s. XBP1s is a crucial transcriptional activator of many UPR genes that produce proteins and chaperones to regulate ER protein folding and trafficking, phospholipid biosynthesis, ER membrane expansion, and ER‐associated protein degradation (ERAD). Several recent studies have implicated the IRE1α‐XBP1 pathway to be at the intersection of several molecular pathways in response to cellular stress. One pathway involves the kinase domain of IRE1α which binds with TNFα receptor‐associated factor 2 (TRAF2) in the cytoplasm, leading to TRAF2 phosphorylation and subsequent activation of the NF‐κB and c‐Jun N terminal kinase (JNK) pathways, thereby contributing to inflammatory and pro‐apoptotic signaling in the cell (Walter and Ron, 2011). Another pathway involves the binding of IRE1 α to pro‐apoptotic proteins Bax and Bak on the mitochondrial outer membrane which leads to mitochondrion‐dependent cell death. Previously, XBP1 was the only known substrate of IRE1α. Interestingly, during ER stress, the endoribonuclease domain of IRE1α was recently found to target a subset of ER‐localized mRNAs, which are subsequently degraded in a process called regulated IRE1‐dependent decay (RIDD), a mechanism that further relieves ER stress (Tabas and Ron, 2011). In addition, RIDD has recently been linked to the translational activation of retinoic acid‐inducible gene 1 (RIG‐1), thereby causing a cell‐autologous NF‐κB‐mediated inflammatory response that amplify the immune response against RNA viruses (Lencer et al., 2015). This IRE1α‐RIDD‐RIG1 pathway suggests an important role for ER stress in immune surveillance and microbial stress response.

Another branch of the UPR signaling involves the PERK, also a type I transmembrane protein with a Ser/Thr kinase domain in its cystolic portion. Upon release from BiP inhibition in response to ER stress, PERK becomes activated in a process similar to IRE1α activation. Activated PERK phosphorylates the Ser51 of the α subunit of eukaryotic translation initiation factor 2 (eIF2α), which competes with eIF2B and reduces the rate of protein translation, thereby resulting in reduced global protein synthesis and a subsequent reduction ER protein‐folding load. In addition to inhibiting global protein synthesis, eIF2α also plays a unique role in selectively promoting the translation of a subset of mRNAs, in particular, the mRNA encoding a bZIP transcription factor ATF4. ATF4 is a key player in several stress‐response pathways and induces the expression of UPR‐associated inflammatory signaling molecules, ER chaperones and trafficking machinery, antioxidative stress responses, and autophagy. A downstream target of ATF4 is CCAAT/enhancer‐binding protein homologous protein (CHOP), which promotes oxidative stress and apoptosis through multiple downstream pathways including ER oxidase 1α, and Ca2+/calmodulin‐dependent protein kinase II (CAMKII). CHOP has also linked to pro‐survival protein Bcl‐2, pro‐apoptotic factors Bim, telomere repeat binding factor 3, and death receptor 5 (Lu et al., 2014).

The third branch of the UPR involves the ATF6α pathway. ATF6α is a type II transmembrane protein with a CREB/ATF bZIP domain at its N‐terminal cytoplasmic portion and belongs to the family of regulated intramembrane proteolysis (RIP)‐regulated bZIP transcription factors. Upon dissociation from BiP in response to ER stress, ATF6α travels to the Golgi apparatus where it cleaved in its luminal domain and transmembrane region by site‐1‐protease (S1P) and S2P, respectively. This releases a free cystolic fragment p50 that migrates to the nucleus and activated ATF6α subsequently stimulates the expression of ER chaperones, transcription factors, the components of ERAD, and ER biogenesis. Dysfunction of ATF6α pathway has been implicated in a variety of disease pathologies. Recently, ATF6α mutations that attenuate its transcriptional activity in response to ER stress are associated with foveal hypoplasia and implicated in achromatopsia, a condition characterized by color blindness and reduced visual acuity (Kohl et al., 2015). Other RIP‐regulated bZIP transcription factors including CREBH and OASIS, and Luman play important and diverse roles in different tissues (Cao and Kaufman, 2014).

Infection and Autoimmunity

The presence of ER stress has been reported in both autoimmune diseases and infections. Autoimmune diseases such as systemic lupus erythematous (SLE), inflammatory bowel disease (IBD), primary biliary cirrhosis (PBC), and autoimmune‐mediated arthritis have been associated with ER stress and the UPR, which may play a significant role in modulating the course and outcome of the pathological states. A study published in 2014 quantified mRNA expression of ER stress markers such as IRE1α, XBP1, CHOP, and PERK in 76 patients with SLE disease activity and found that IRE1, PERK, and CHOP mRNA transcripts were downregulated in SLE patients while total XBP1, XBP1s, and mesencephalic astrocyte‐derived neurotrophic factor (an ER stress‐induced cytoprotective protein) were upregulated (Petrova et al., 2003; Wang et al., 2014). Another study published in 2010 used a two‐hybrid screen in the cDNA library of a patient with lupus nephritis, using an O‐81 single‐chain Fv as bait. An alternative splice variant of the homocysteine‐induced ER protein (Herp) transcript was discovered to exhibit moderate binding to the O‐81 mAb, and immunization with the HERP protein was necessary for formation of anti‐dsDNA antibodies even with the presence of oligonucleosome antigens (Hirabayashi et al., 2010). Lee et al. (2015) found that, in response to ER stress inducer thapsigargin, levels of IRE1, ATF6, PERK, and p‐eIF2α decreased in T lymphocytes of lupus patients compared to those of normal controls, while pro‐apoptotic molecules Bax and caspase 6 were elevated in patients with SLE. In the IBD field, deletion of Xbp1 in intestinal epithelial cells of mice led to histological findings of IBD, symptoms of enteritis, and increased signs of ER stress (Kaser et al., 2008). In IBD patients, XBP1 SNPs rs5997391, rs5762795, and rs35873774 were found to be strongly associated with IBD (Kaser et al., 2010). Both p‐eIF2α and one of its cytosolic kinases dsRNA‐activated protein kinase (PKR) in colonic epithelial cells are protective against chemical‐induced colitis by inducing protective UPR signaling including ER chaperones (Siyan et al., 2012; Cao and Kaufman, 2013a; Cao et al., 2014). Interestingly, p‐eIF2α, but not PKR, is required for the secretory function of Paneth cells in the small intestine by inducing ER chaperones, transcription factors, ERAD machinery, and autophagy. The expression of a non‐phosphorylatable eIF2α in intestinal epithelial cells increased the susceptibility of mice to salmonella infection and chemical‐induced colitis (Cao et al., 2014). The protective role of ER chaperone response in intestinal epithelial cells upon mucosal inflammation was demonstrated using murine models with deletion of ER chaperone gene P58IPK and Atf6α, an transcriptional activator of multiple ER chaperone genes. Furthermore, chemical chaperones 4‐phenylbutyrate (PBA) and tauroursodeoxycholate (TUDCA) were shown to alleviate intestinal inflammation in several murine models of IBD, by reducing ER stress and apoptosis in intestinal epithelial cells (Cao et al., 2013; Luo and Cao, 2015). Another study recently discovered that β‐Arrestin2‐mediated inflammation‐induced colitis through positive regulation of p53‐upregulated mediator of apoptosis (PUMA) activity in mice, and β‐Arrestin2 was also upregulated in IBD patient intestinal tissue (Zeng et al., 2015). Anti‐citrullinated antibody is a highly specific marker of rheumatoid arthritis, and anti‐citrullinated calreticulin, an essential ER chaperone, is present in synovial tissue of joints and binds preferentially to the shared epitope domain of β1 domain of the HLA‐DR found in RA patients (Ling et al., 2013, 2006). An exome‐sequencing study in five families with hereditary autoimmune disorders (including arthritis and interstitial lung disease) revealed mutations in coatomer protein complex, subunit α (COPA, known to mediate ER‐Golgi vesicular transport as a vesicular coat protein). Additional experiments showed that defects in COPI vesicular transport leads to ER stress and an increased T helper 17 response and proliferation (Watkin et al., 2015). PBC lesions have deregulated autophagy and senescence in biliary epithelial cells, which is linked to increased ER stress (Sasaki et al., 2014). Although the functional role of ER stress in the pathogenesis of PBC is unknown. In patients with limited cutaneous systemic sclerosis, the expression of ER stress markers BiP, ATF4, ATF6, and XBP1s were relatively increased in peripheral blood mononuclear cells (Lenna et al., 2013). Anti‐chaperone antibodies have been discovered in a number of autoimmune diseases, including inflammatory bowel disease, myasthenia gravis, RA, SLE, systemic sclerosis, primary biliary cirrhosis, juvenile autoimmune arthritis, and autoimmune hepatitis (Nagayama et al., 1994; Kreisel et al., 1999; Eggleton et al., 2000; Bodman‐Smith et al., 2004; Watanabe et al., 2006; Goeb et al., 2009; Komurasaki et al., 2010; Tarr et al., 2010; Weber et al., 2010). However, the precise mechanism of how these antibodies are generated and how they contribute to the progression of the disease are still being studied. PERK was recently shown to be involved in initiating the JAK1‐STAT3 pathway in microglia and astrocytes in neuroinflammation (Meares et al., 2014). In multiple sclerosis experimental models, mice with oligodendrocyte‐specific knockout of Perk exhibit impaired UPR and exacerbated experimental autoimmune encephalopathy (EAE) (Hussien et al., 2014). Moreover, activation of PERK in oligodendrocytes was shown to confer resistance against EAE (Lin et al., 2013). Recent studies also linked ER stress to tumor immunity. ER chaperones BiP, gp96, and calreticulin were found on plasma membranes and may act as damage associate molecular patterns and activate immune responses. Release of BiP and gp96 into the extracellular matrix have been shown to induce tumor immunity through CD8+ T‐cells (Udono et al., 1994; Tamura et al., 2011). Immunity against fibrosarcoma can be attained by binding of extracellular gp96 to CD91, endocytosis of the chaperone‐receptor complex, and presentation on MHC I and MHC II to CD4+ and CD8+ T‐cells (Srivastava, 2002).

Infection with viruses, bacteria, or parasites has been shown to induce ER stress and activate the UPR. Envelope viruses program the cell to produce massive quantities of viral protein, including, e.g., the hemagglutinin protein of the influenza virus and the spike protein of SARS‐CoV, causing ER stress and initiating the UPR (Watowich et al., 1991; Chan et al., 2006). Overexpression of IRE1α protected a non‐small cell lung carcinoma cell line H2199 cells from avian coronavirus infectious bronchitis virus infection‐induced apoptosis (Fung et al., 2014), whereas the deletion of XBP1, the downstream target of IRE1α in fibroblasts delayed propagation by murine cytomegalovirus (Drori et al., 2014). Knockout mice deficient in autophagy protein Map1‐LC3b displayed increased expression of IL‐17 and lung pathology upon infection with respiratory syncytial virus. Inhibiting IL‐1 production abolished this phenotype, and knockdown of IRE1 inhibited production of IL‐1β (Reed et al., 2015). The expression of BiP and Grp94 in coxsackievirus B3‐induced myocarditis was increased and correlated with severity of symptoms. Upon induction of ER stress within cardiomyocytes, cardiac function was compromised and the myocarditis was exacerbated, potentially through elevated levels of inflammatory cytokines including IL‐6, IL‐12, TNFα, and MCP‐1 (Zha et al., 2015). Pseudomonas aeruginosa infection complicates chronic lung diseases including cystic fibrosis and chronic obstructive pulmonary disease. A recent study showed that conditioned media containing Pseudomonas virulence factors pyocyanin and elastase and alkaline protease was sufficient to induce XBP1s, CHOP, BiP, and GADD34 expression in primary bronchial epithelial cells. The activation of most of the ER stress markers were dependent on TGFβ activated kinase‐1 and p38 MAPK, except the induction of GADD34. Heme‐regulated eIF2α kinase (HRI), instead of ER stress sensor PERK, was shown to induce the expression of GADD34, which plays a cytoprotective role in primary bronchial epithelial cells against Pseudomonas infection (van 't Wout et al., 2015). Plasmodium burghei infection also induces ER stress, which allowed hepatocytes to adopt radical metabolic changes during the infection. This metabolic shift was shown to help Plasmodium burghei establish successful infection, namely increasing their exoerythrocytic forms. The activation of XBP1s induces phosphotidylcholine synthesis, which has been shown to be beneficial for growth of the parasite (Inacio et al., 2015).

Metabolic Disease

Although sedentary lifestyles and excess caloric intake are considered culprits on the macroscopic scale for increases in rates of metabolic disorders including type 2 diabetes and obesity, recent scientific literature has shed light on the systems gone awry at the molecular level related to ER homeostasis (Cao and Kaufman, 2013b). In mammals, the liver is the master organ in regulating glucose metabolism. Insulin resistance in the liver promotes gluconeogenesis and lipogenesis, which contributes to subsequent hyperglycemia and hyperlipidemia (Cao and Kaufman, 2013b). In the setting of ER stress, insulin resistance develops through IRE1α‐mediated activation of JNK and IKK, which subsequently inhibits insulin action by downstream serine phosphorylation of insulin receptor substrate (IRS) 1 and 2. In addition to IRE1α‐mediated activation, JNK can be induced by CAMKII and eIF2α kinase PKR in the setting of ER stress to induce insulin resistance (Timmins et al., 2009). In addition to suppressing insulin action, ER stress may lead to downstream activation of transcription factors that are involved in liver gluconeogenesis and lipogenesis. Among these transcription factors is CREBH, a RIP‐regulated bZIP transcription factor that contributes to the activation of gluconeogenic and inflammatory response genes. However, another pathway mediated by ATF6α suppresses gluconeogenesis via CREB‐regulated transcription coactivator 2 (CRTC2) (Wang et al., 2009). Although several pathways intersect and are involved in insulin resistance in the liver, it remains an area of mystery how these pathways are regulated in response to different metabolic signals. In addition to glucose dysregulation, lipids can accumulate in the liver in the setting of ER stress which further contributes to insulin resistance. There is recent evidence to suggest that PPARβ/δ serves a protective role in insulin resistance via an AMPK‐dependent signaling pathway (Salvado et al., 2014). However, the exact mechanisms and role players in insulin resistance remain controversial and much remains to be unearthed in future studies.

Type 2 diabetes is characterized by pancreatic β cell dysfunction against a background of chronic low‐grade inflammation (Donath et al., 2005). Recent evidence demonstrates that ER stress and inflammation are critical contributors to impaired β cell homeostasis in the pathogenesis of type 2 diabetes. ER stress leads to inflammatory cytokine secretion, and these inflammatory cytokines, in particular IL23, IL24, and IL33, amplify ER stress in pancreatic β cells (Hasnain et al., 2014). Another cytokine IL1β, activated by NLRP3 inflammasome during ER stress, is also implicated in pancreatic inflammation and autophagy (Montane et al., 2014). The key molecule in this signaling cascade is thioredoxin‐interacting protein (TXNIP) that links ER stress and inflammation in β cell pathology in a murine model of type 2 diabetes (Oslowski et al., 2012). TXNIP expression is induced by IRE1‐ and PERK‐mediated pathways. TXNIP subsequently activates NLRP3 inflammasome and elevates IL1β secretion that causes pancreatic inflammation (Abderrazak et al., 2015). These data suggest that ER stress and inflammation form a vicious cycle in pancreatic β cell dysfunction in type 2 diabetes. Obesity involves a multifactorial disease process that leads to its development and maintenance. Recent studies suggest that activation of ER stress and NF‐κB pathways in the hypothalamus impair leptin signaling, which predisposes the individual to diet‐induced obesity (Ropelle et al., 2010; Williams, 2012; Zhou and Rui, 2013). Other studies propose a mechanistic approach that involves chronic excessive food intake leading to adipocyte hypertrophy as the source of ER stress, which was shown to initiate a pro‐inflammatory state in adipose tissue and activate downstream metabolic pathways that promote insulin resistance. These adipocytes release MCP‐1, M‐CSF1, MIF to recruit macrophages that release additional MCPs and inflammatory cytokines, such as TNFα, IL6, IL1β, as well as initiate iNOS signaling, to stimulate inflammation (Schaffler and Scholmerich, 2010). Free fatty acids released by inflamed adipocytes induce Toll‐like receptor 4 (TLR4) to further amplify insulin resistance and inflammation. The resultant increase in serum levels of fatty acids, lipids, and leptin, as well as decrease in adiponectin, promote lipid accumulation and lipotoxicity, creating a cycle that stimulates and maintains obesity (Ye et al., 2014).

Neurological Disease

Amyotrophic lateral sclerosis (ALS) is a debilitating neurological disease in which motor neurons are selectively lost in the motor cortex, spinal cord, and peripheral nervous system. Pathologically, ALS is characterized by gliosis replacing affected motor neurons. The volume of myelinated fibers in motor neurons is decreased, and the ventral nerve roots are thinned. Neuropathological findings often include intracellular inclusions suggestive of impaired protein folding: ubiquitinated aggregates, TDP‐43 aggregates (common in non‐SOD1 ALS), and phosphorylated and nonphosphorylated neurofilament inclusions (Arisato et al., 2003). The majority of ALS cases are sporadic (sALS), but of the 5–10% of cases that are familial (fALS), 20% have been linked to mutations in Cu/Zn superoxide dismutase (SOD1) (Deng et al., 1993; Tobisawa et al., 2003a; Byrne et al., 2011). Over a hundred mutations within the SOD1 gene have been discovered, the most studied of which is G93A, which was able to recapitulate the ALS phenotype in a G93A mSOD1 transgenic mouse. However, changes in the functionality of SOD1 have a poor correlation with disease severity and progression; rather, the ability of mSOD1 to form aggregates that localize to the ER is a strong indication of disease (Borchelt et al., 1994).

In 2003, Tobisawa et al. first demonstrated that mSOD1 physically associated with the ER membranes and was implicated in the ERAD pathway in the pathogenesis of ALS. Additionally, mSOD1 (L84V and H46R) transgenic mice displayed high expression of BiP prior to onset of symptoms of motor neuron degeneration. These results strongly suggested that the accumulation of mSOD1 potentially increased ER stress and activated the UPR (Tobisawa et al., 2003b). In 2006, another study showed that mSOD1 forms aggregates in the ER and interacts with BiP in spinal motor neurons of symptomatic G93A mSOD1 transgenic mice (Kikuchi et al., 2006). It was also found that ER stress markers PDI, p‐eIF2α along with ATF6, IRE1, PERK, Erp57, BiP, and CHOP are upregulated in post‐mortem spinal cord samples of human patients with sporadic ALS (Atkin et al., 2008).

Motor neurons in ALS patients undergo apoptosis, leading to the classical symptoms of motor dysfunction and paralysis. Spinal cords of ALS patients possess activated caspase‐1, caspase‐3, and caspase‐9 and decreased levels of Bcl‐2 (Pasinelli et al., 2000; Guegn et al., 2001; Inoue et al., 2003). Overexpression of Bcl‐2 in transgenic mSOD1 mouse models slows onset of the disease (Kostic et al., 1997). Persistent ER stress, through IRE1α, can induce apoptosis via cleavage and activation of caspase 12, an upstream activator of the apoptotic pathway. Interestingly, deletion of Xbp1, the downstream target of IRE1α, ameliorates mSOD1 aggregation and toxicity in both NSC34 motor neuron cell lines and G86R mSOD1 transgenic mice. In fact, lifespan is increased in XBP1‐deficient G86R mSOD1 mice compared to transgenic mice with endogenous levels of XBP1, presumably through shunting towards the autophagy pathway rather than the UPR (Hetz et al., 2009). A 2004 study by Wootz et al. (2004) demonstrated that in the transgenic G93A mSOD1 mouse model of ALS, caspase‐12 is cleaved during early stages of the disease, with high procaspase‐12 turnover rates (as evidenced by high mRNA levels but low protein expression). Kieran et al. (2007) showed that BH3‐only protein p53‐upregulated mediator of apoptosis (PUMA) expression coincided with an increase CHOP levels, which are thought to mediate the transition from pro‐survival to pro‐apoptosis. Moreover, abrogation of Puma expression in mSOD1 G93A mice delayed onset of symptoms and slowed progression of disease without extending lifespan. Another apoptotic pathway may occur through Apoptosis signal‐regulating kinase 1 (ASK1), in which ASK1 and TRAF2 are recruited by IRE1 to the ER membrane surface and then activated. Nishitoh et al. in 2008 reported that mSOD1 inhibited ERAD and induced ER stress by interacting with Derlin‐1 and thus activating the ER stress‐ASK1 apoptotic pathway. Ablating ASK1 expression extended lifespan of G93A mSOD1 mice and delayed progression of disease with no significant difference in age of onset of symptoms (Nishitoh et al., 2008). However, it remains unknown how mSOD1 regulates Derlin‐1 and ERAD in the dysfunction and apoptosis of motor neurons.

The reason behind why motor neurons are specifically affected in ALS still is largely unknown. It was postulated that the synthesis of large amounts of proteins aided in triggering ER stress and that motor neurons were especially sensitive to their continual production of neurotransmitters. In 2008, Saxena et al. discovered that certain subtypes of motor neurons were more resistant to ER stress, specifically fast fatigue‐resistant and slow motor neurons. Neurons that were sensitive to ER stress were fast fatiguable, and treatment with salubrinal, an ER stress protective agent, attenuated disease progression after onset of symptoms and extended the lifespan of G93A mSOD1 mice (Saxena et al., 2009). This study was followed up by another that showed that the ER cochaperone SIL1 was specifically expressed in ER stress‐resistant motor neurons. The AMPA Receptor antagonist CNQX blocked motor neuron excitability and also decreased SIL1 expression. SIL1 null or heterozygous mice displayed an increased predilection for UPR signaling in response to neuronal lesions induced by crush injuries. Overexpression of SIL1 in G93A mice significantly increased lifespan and diminished disease symptoms, especially in G93A‐s mice, which further demonstrated the protective role of SIL1 in motor neurons (de L'Etang et al., 2015). The inability of salubrinal to completely reverse the effects of the disease in G93A mSOD1 mice strongly suggests the presence of other mechanisms underlying ALS, including inflammatory processes. Sporadic ALS patients have been shown to possess pro‐inflammatory cytokines MCP‐1α and complement proteins in their cerebral spinal fluid and serum (Simpson et al., 2004; Goldknopf et al., 2006). In a study of 144 sALS patients, IL‐18 was specifically found to be elevated in the CSF and sera compared to the control group (Italiani et al., 2014). Inflammatory cytokine IFNγ was shown to trigger CHOP expression in spinal cord neurons in sALS patients via induction of iNOS. TNFα exposure to astrocytes for 72 h in culture led to upregulation of glutamate receptors and enhanced the risk for glutamatergic toxicity (Dumont et al., 2014). When a TNFα antagonist was given to mSOD1 mice, there was a small but significant increase in lifespan (West et al., 2004). One study also showed that release of mSOD1 by neurons activated microglia and promoted cell death (Urushitani et al., 2006). Other studies also found that cyclooxygenase‐2 was increased in spinal cords of ALS patients and that celecoxib delayed onset of the disease in mice, although it did not inhibit progression (Yasojima et al., 2001; Drachman et al., 2002; Yiangou et al., 2006). Areas that remain unanswered involve elucidating/reconciling the mechanism behind ER stress‐induced apoptosis in motor neurons, the various other mutations behind fALS (including TDP‐43, alsin, senataxin, VAPB, dynactin, and angiogenin), the triggers of ER stress in sALS, and the role of SIL1 in motor neurons. Salubrinal has been shown to alleviate symptoms and slow progression of the disease in mouse models but does not completely cure ALS in the mSOD1 mouse model, suggesting multiple mechanisms besides ER stress behind selective motor neuron loss.

Parkinson's disease is a neurodegenerative disease in which the number of dopamine‐releasing neurons of the substantia nigra pars compacta is compromised. The cause of the neuronal loss is largely unknown, although it has been postulated that ER stress and inflammatory mechanisms may contribute to neuronal death. Three proteins have been associated with the pathogenesis of PD: parkin, α‐synuclein, and C‐terminal esterase L1 (UCH‐L1). Despite the role of α‐synuclein being relatively unknown, it forms aggregates called Lewy bodies that are characteristic of PD and late‐stage neurodegenerative diseases. Cooper et al. (2006) discovered that α‐synuclein blocked ER‐Golgi vesicular trafficking, which was rescued by Rab1, a guanosine triphosphatase. The expression of parkin, a ubiquitin E3 ligase, is induced by ER stress, and its activity was shown to protect against ER stress‐mediated apoptosis in neurons (Imai et al., 2000). UCH‐L1 has been linked to ERAD through ubiquitination of unfolded proteins (Liu et al., 2002). In addition, the expression of ER foldase PDI is induced in neurons of PD patients, and PDI is also found in Lewy bodies in patients with PD (Conn et al., 2004).

PD has also a well‐recognized inflammatory component. Release of α‐synuclein extracellularly may activate microglial cells and lead to an inflammatory reaction (Zhang et al., 2005; Reynolds et al., 2008). CD4+ T regulatory cells were also found to mediate microglial activation by nitrated α‐synuclein (Benner et al., 2008). In addition, exposure of LPS was sufficient to induce dopaminergic neuron loss, presumably through microglial TLR4 since neither astrocytes nor neurons expressed TLR4 at significant levels (Castano et al., 1998; Kim et al., 2000). LPS exposure also led to upregulation of COX‐2 and iNOS (Hunter et al., 2007). Reactive oxygen species, IL‐1β, TNF‐α, and NO have also been implicated in the inflammatory response mediated by microglial activation (Hirsch et al., 2012). The importance of the ER stress and ERAD in familial forms of Parkinson's disease implies additional downstream mechanisms such as oxidative stress, mitochondrial dysfunction, and inflammatory mechanisms may be involved in the same pathway. Further studies should identify how UPR pathways, including IRE1 and XBP1, affect neuroinflammation in the pathogenesis of PD.

Discussion

ER stress and inflammation are linked through numerous mechanisms and in various disease states, including autoimmunity and infection, metabolic disorders, and neurodegenerative diseases. However, it is often unclear which of these two pathways contains the initiating signal. For instance, in obesity, ER stress triggers the inflammatory pathway to generate pro‐inflammatory adipocytes, which later may exacerbate ER stress. Meanwhile, IFNγ, through induction of iNOS, initiates CHOP expression and downstream pro‐apoptotic signaling in spinal cords neurons of sporadic ALS patients. In Parkinson's disease, ER stress and inflammation appear to work in parallel, potentially with a common upstream signal (e.g., α‐synuclein). It appears as though how and when ER stress and inflammation operate in concert remains highly dependent on the context of specific diseases and signaling molecules, especially since numerous molecules are still being found to have novel functions in the ER stress and inflammatory pathways.

Secretory cells are canonically prone to ER stress, due to the massive production of secretory proteins. Moreover, release of misfolded protein may promote an inflammatory response in secretory cells. Many diseases, including IBD, Parkinson's disease, diabetes, rheumatoid arthritis, and states of viral infection, are perpetuated by the release of antigenic factors that play a dual role in inducing the UPR and inflammation. On the other hand, non‐secretory cells have been shown in myriads of cases to be involved in both pathways. Under inflammatory conditions, ER homeostasis may be easily disrupted even without a high protein folding load. More and more evidence suggest that ER dysfunction is a universal phenomenon in inflamed cells regardless of the cells’ secretory status. Therapeutics for diseases that have been clinically established as inflammatory in origin often focus on anti‐inflammatory treatments, which show various efficacy and significant side effects. Treatments targeting both ER stress and inflammation simultaneously may open a new avenue for diseases with pathogenic contributions from both pathways.

Stewart Siyan Cao and Katherine L. Luo contributed equally to this work.

Literature Cited

  1. Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, Rouis M. 2015. NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol 4:296–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arisato T, Okubo R, Arata H, Abe K, Fukada K, Sakoda S, Shimizu A, Qin XH, Izumo S, Osame M, Nakagawa M. 2003. Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Acta Neuropathol 106:561–568. [DOI] [PubMed] [Google Scholar]
  3. Atkin JD, Farg MA, Walker AK, McLean C, Tomas D, Horne MK. 2008. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis 30:400–407. [DOI] [PubMed] [Google Scholar]
  4. Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE. 2008. Nitrated alpha‐synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLos ONE 3:e1376. doi: 10.1371/journal.pone.0001376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bodman‐Smith MD, Fife MF, Wythe H, Corrigal VM, Panayi GS, Wedderburn LR, Woo P. 2004. Anti‐BiP antibody levels in juvenile idiopathic arthritis (JIA). Rheumatology 43:1305–1306. [DOI] [PubMed] [Google Scholar]
  6. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH, Jr. , Price DL, Sisodia SS, Cleveland DW. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292–8296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. 2011. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta‐analysis. J Neurol Neurosurg Psychiatry 82:623–627. [DOI] [PubMed] [Google Scholar]
  8. Cao SS, Kaufman RJ. 2012. Unfolded protein response. Curr Biol 22:R622–R626. [DOI] [PubMed] [Google Scholar]
  9. Cao SS, Kaufman RJ. 2013a. PKR in DSS‐induced colitis: A matter of genetic background and maternal microflora? Inflamm Bowel Dis 19:E49–E50. [DOI] [PubMed] [Google Scholar]
  10. Cao SS, Kaufman RJ. 2013b. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin Ther Targets 17:437–448. [DOI] [PubMed] [Google Scholar]
  11. Cao SS, Kaufman RJ. 2014. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 21:396–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cao SS, Wang M, Harrington JC, Chuang BM, Eckmann L, Kaufman RJ. 2014. Phosphorylation of eIF2a is dispensable for differentiation but required at a posttranscriptional level for paneth cell function and intestinal homeostasis in mice. Inflamm Bowel Dis 20:712–722. [DOI] [PubMed] [Google Scholar]
  13. Cao SS, Zimmermann EM, Chuang BM, Song B, Nwokoye A, Wilkinson JE, Eaton KA, Kaufman RJ. 2013. The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. Gastroenterology 144:989–1000 e1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Castano A, Herrera AJ, Cano J, Machado A. 1998. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70:1584–1592. [DOI] [PubMed] [Google Scholar]
  15. Chan C‐P, Siu K‐L, Chin K‐T, Yuen K‐Y, Zheng B, Jin D‐Y. 2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol 80:9279–9287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Conn KJ, Gao WW, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM. 2004. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 1022:164–172. [DOI] [PubMed] [Google Scholar]
  17. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu KN, Xu KX, Strathearn KE, Liu F, Cao SS, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, LaBaer J, Rochet JC, Bonini NM, Lindquist S. 2006. Alpha‐synuclein blocks ER‐Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313:324–328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. de L'Etang AF, Maharjan N, Brana MC, Ruegsegger C, Rehmann R, Goswami A, Roos A, Troost D, Schneider BL, Weis J, Saxena S. 2015. Marinesco‐Sjogren syndrome protein SIL1 regulates motor neuron subtype‐selective ER stress in ALS. Nat Neurosci 18:227–238. [DOI] [PubMed] [Google Scholar]
  19. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C, Parge HE, Ahmed A, Roses AD, Hallewell RA, Pericak‐Vance MA, Siddique T. 1993. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261:1047–1051. [DOI] [PubMed] [Google Scholar]
  20. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M. 2005. Mechanisms of beta‐cell death in type 2 diabetes. Diabetes 54:S108–S113. [DOI] [PubMed] [Google Scholar]
  21. Drachman DB, Frank K, Dykes‐Hoberg M, Teismann P, Almer G, Przedborski S, Rothstein JD. 2002. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52:771–778. [DOI] [PubMed] [Google Scholar]
  22. Drori A, Messerle M, Brune W, Tirosh B. 2014. Lack of XBP‐1 impedes murine cytomegalovirus gene expression. PLos ONE 9: e110942. doi: 10.1371/journal.pone.0110942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Dumont AO, Goursaud S, Desmet N, Hermans E. 2014. Differential regulation of glutamate transporter subtypes by pro‐inflammatory cytokine TNF‐alpha in cortical astrocytes from a rat model of amyotrophic lateral sclerosis. PLos ONE 9:8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Eggleton P, Ward FJ, Johnson S, Khamashta MA, Hughes GRV, Hajela VA, Michalak M, Corbett EF, Staines NA, Reid KBM. 2000. Fine specificity of autoantibodies to calreticulin: Epitope mapping and characterization. Clin Exp Immunol 120:384–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fung TS, Liao Y, Liu DX. 2014. The endoplasmic reticulum stress sensor IRE1 alpha protects cells from apoptosis induced by the coronavirus infectious bronchitis virus. J Virol 88:12752–12764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Goeb V, Thomas‐L'Otellier M, Daveau R, Charlionet R, Fardellone P, Le Loet X, Tron F, Gilbert D, Vittecoq O. 2009. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 11:R38. doi: 10.1186/ar2644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, Yen AA, Appel SH. 2006. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem Biophys Res Commun 342:1034–1039. [DOI] [PubMed] [Google Scholar]
  28. Guegn C, Vila M, Rosoklija G, Hays AP, Przedborski S. 2001. Recruitment of the mitochondrial‐dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21:6569–6576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hasnain SZ, Borg DJ, Harcourt BE, Tong H, Sheng YHH, Ng CP, Das I, Wang R, Chen ACH, Loudovaris T, Kay TW, Thomas HE, Whitehead JP, Forbes JM, Prins JB, McGuckin MA. 2014. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med 20:1417–1426. [DOI] [PubMed] [Google Scholar]
  30. Hetz C. 2012. The unfolded protein response: Controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89–102. [DOI] [PubMed] [Google Scholar]
  31. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH. 2009. XBP‐1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23:2294–2306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hirabayashi Y, Oka Y, Ikeda T, Fujii H, Ishii T, Sasaki T, Harigae H. 2010. The endoplasmic reticulum stress‐inducible protein, Herp, is a potential triggering antigen for anti‐DNA response. J Immunol 184:3276–3283. [DOI] [PubMed] [Google Scholar]
  33. Hirsch EC, Vyas S, Hunot S. 2012. Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord 18:S210–S212. [DOI] [PubMed] [Google Scholar]
  34. Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing GY. 2007. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100:1375–1386. [DOI] [PubMed] [Google Scholar]
  35. Hussien Y, Cavener DR, Popko B. 2014. Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination. Glia 62:680–691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Imai Y, Soda M, Takahashi R. 2000. Parkin suppresses unfolded protein stress‐induced cell death through its E3 ubiquitin‐protein ligase activity. J Biol Chem 275:35661–35664. [DOI] [PubMed] [Google Scholar]
  37. Inacio P, Zuzarte‐Luis V, Ruivo MT, Falkard B, Nagaraj N, Rooijers K, Mann M, Mair G, Fidock DA, Mota MM. 2015. Parasite‐induced ER stress response in hepatocytes facilitates Plasmodium liver stage infection. EMBO Rep pii: e201439979. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, Misawa H, Itohara S, Takahashi R. 2003. The crucial role of caspase‐9 in the disease progression of a transgenic ALS mouse model. EMBO J 22:6665–6674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Bossu P, Migliorini P, Siciliano G, Boraschi D. 2014. Evaluating the levels of interleukin‐1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation 11:94. doi: 10.1186/1742-2094-11-94 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kaser A, Lee A‐H, Franke A, Glickman JN, Zeissig S, Tilg H, Nieuwenhuis EES, Higgins DE, Schreiber S, Glimcher LH, Blumberg RS. 2008. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134:743–756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kaser A, Martinez‐Naves E, Blumberg RS. 2010. Endoplasmic reticulum stress: Implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 26:318–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kieran D, Woods I, Villunger A, Strasser A, Prehn JHM. 2007. Deletion of the BH3‐only protein puma protects motoneurons from ER stress‐induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci USA 104:20606–20611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kikuchi H, Almer G, Yamashita S, Guegan C, Nagai M, Xu ZS, Sosunov AA, McKhann GM, Przedborski S. 2006. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase‐1 in an ALS model. Proc Natl Acad Sci USA 103:6025–6030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide‐induced neurotoxicity in the rat brain: Role of microglia. J Neurosci 20:6309–6316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kohl S, Zobor D, Chiang WC, Weisschuh N, Staller J, Menendez IG, Chang S, Beck SC, Garcia Garrido M, Sothilingam V, Seeliger MW, Stanzial F, Benedicenti F, Inzana F, Heon E, Vincent A, Beis J, Strom TM, Rudolph G, Roosing S, Hollander AI, Cremers FP, Lopez I, Ren H, Moore AT, Webster AR, Michaelides M, Koenekoop RK, Zrenner E, Kaufman RJ, Tsang SH, Wissinger B, Lin JH. 2015. Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia. Nat Genet 47:757–765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Komurasaki R, Imaoka S, Tada N, Okada K, Nishiguchi S, Funae Y. 2010. LKM‐1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2 D6. Drug Metab Pharmacokinet 25:84–92. [DOI] [PubMed] [Google Scholar]
  47. Kostic V, Jackson‐Lewis V, de Bilbao F, Dubois‐Dauphin M, Przedborski S. 1997. Bcl‐2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559–562. [DOI] [PubMed] [Google Scholar]
  48. Kreisel W, Siegel A, Bahler A, Spamer C, Schiltz E, Kist M, Seilnacht G, Klein R, Berg PA, Heilmann C. 1999. High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: A possible role of gut‐derived bacterial antigens in its aetiology? Scand J Gastroenterol 34:623–628. [DOI] [PubMed] [Google Scholar]
  49. Lee W‐S, Sung M‐S, Lee E‐G, Yoo H‐G, Cheon Y‐H, Chae H‐J, Yoo W‐H. 2015. A pathogenic role for ER stress‐induced autophagy and ER chaperone GRP78/BiP in T lymphocyte systemic lupus erythematosus. J Leukoc Biol 97:425–433. [DOI] [PubMed] [Google Scholar]
  50. Lencer WI, DeLuca H, Grey MJ, Cho JA. 2015. Innate immunity at mucosal surfaces: The IRE1‐RIDD‐RIG‐I pathway. Trends Immunol 36:401–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lenna S, Farina AG, Martyanov V, Christmann RB, Wood TA, Farber HW, Scorza R, Whitfield ML, Lafyatis R, Trojanowska M. 2013. Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension. Arthritis Rheum 65:1357–1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lin WS, Lin YF, Li J, Fenstermaker AG, Way SW, Clayton B, Jamison S, Harding HP, Ron D, Popko B. 2013. Oligodendrocyte‐specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci 33:5980–5991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ling S, Cline EN, Haug TS, Fox DA, Holoshitz J. 2013. Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling. Arthritis Rheum 65:618–626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. 2006. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum 54:3423–3432. [DOI] [PubMed] [Google Scholar]
  55. Liu YC, Fallon L, Lashuel HA, Liu ZH, Lansbury PT. 2002. The UCH‐L1 gene encodes two opposing enzymatic activities that affect alpha‐synuclein degradation and Parkinson's disease susceptibility. Cell 111:209–218. [DOI] [PubMed] [Google Scholar]
  56. Lu M, Lawrence DA, Marsters S, Acosta‐Alvear D, Kimmig P, Mendez AS, Paton AW, Paton JC, Walter P, Ashkenazi A. 2014. Cell death. Opposing unfolded‐protein‐response signals converge on death receptor 5 to control apoptosis. Science 345:98–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Luo K, Cao SS. 2015. Endoplasmic reticulum stress in intestinal epithelial cell function and inflammatory bowel disease. Gastroenterol Res Pract 2015:328791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Meares GP, Liu Y, Rajbhandari R, Qin H, Nozell SE, Mobley JA, Corbett JA, Benveniste EN. 2014. PERK‐dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress‐induced inflammation. Mol Cell Biol 34:3911–3925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Montane J, Cadavez L, Novials A. 2014. Stress and the inflammatory process: A major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 7:25–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Nagayama S, Yokoi T, Tanaka H, Kawaguchi Y, Shirasaka T, Kamataki T. 1994. Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. J Toxicol Sci 19:163–169. [DOI] [PubMed] [Google Scholar]
  61. Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H. 2008. ALS‐linked mutant SOD1 induces ER stress‐ and ASK1‐dependent motor neuron death by targeting Derlin‐1. Genes Dev 22:1451–1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Oslowski CM, Hara T, O'Sullivan‐Murphy B, Kanekura K, Lu SM, Hara M, Ishigaki S, Zhu LHJ, Hayashi E, Hui ST, Greiner D, Kaufman RJ, Bortell R, Urano F. 2012. Thioredoxin‐interacting protein mediates ER stress‐induced beta cell death through initiation of the inflammasome. Cell Metab 16:265–273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Pasinelli P, Houseweart MK, Brown RH, Jr. , Cleveland DW. 2000. Caspase‐1 and ‐3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase‐mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97:13901–13906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Petrova PS, Raibekas A, Pevsner J, Vigo N, Anafi M, Moore MK, Peaire AE, Shridhar V, Smith DI, Kelly J, Durocher Y, Commissiong JW. 2003. MANF—A new mesencephalic, astrocyte‐derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci 20:173–187. [DOI] [PubMed] [Google Scholar]
  65. Reed M, Morris SH, Owczarczyk AB, Lukacs NW. 2015. Deficiency of autophagy protein Map1‐LC3b mediates IL‐17‐dependent lung pathology during respiratory viral infection via ER stress‐associated IL‐1. Mucosal Immunol. doi: 10.1038/mi.2015.3. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Reynolds AD, Kadiu I, Garg SK, Glanzer JG, Nordgren T, Ciborowski P, Banerjee R, Gendelman HE. 2008. Nitrated alpha‐synuclein and microglial neuroregulatory activities. J Neuroimmune Pharmacol 3:59–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J, de Souza CT, Moraes JC, Prada PO, Guadagnini D, Marin RM, Oliveira AG, Augusto TM, Carvalho HF, Velloso LA, Saad MJA, Carvalheira JBC. 2010. IL‐6 and IL‐10 anti‐inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKK beta and ER stress inhibition. PLoS Biol 8:e1000465. doi: 10.1371/journal.pbio.1000465 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  68. Salvado L, Barroso E, Gomez‐Foix AM, Palomer X, Michalik L, Wahli W, Vazquez‐Carrera M. 2014. PPAR beta/delta prevents endoplasmic reticulum stress‐associated inflammation and insulin resistance in skeletal muscle cells through an AMPK‐dependent mechanism. Diabetologia 57:2126–2135. [DOI] [PubMed] [Google Scholar]
  69. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. 2014. A possible involvement of endoplasmic reticulum stress in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis. Hepatology 60:350A–350A. [DOI] [PubMed] [Google Scholar]
  70. Saxena S, Cabuy E, Caroni P. 2009. A role for motoneuron subtype‐selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12:627–636. [DOI] [PubMed] [Google Scholar]
  71. Schaffler A, Scholmerich J. 2010. Innate immunity and adipose tissue biology. Trends Immunol 31:228–235. [DOI] [PubMed] [Google Scholar]
  72. Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. 2004. Increased lipid peroxidation in sera of ALS patients—A potential biomarker of disease burden. Neurology 62:1758–1765. [DOI] [PubMed] [Google Scholar]
  73. Siyan S, Song BB, Kaufman RJ. 2012. PKR protects colonic epithelium against colitis through the unfolded protein response and prosurvival signaling. Inflamm Bowel Dis 18:1735–1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Srivastava P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Ann Rev Immunol 20:395–425. [DOI] [PubMed] [Google Scholar]
  75. Tabas I, Ron D. 2011. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13:184–190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Tamura Y, Hirohashi Y, Kutomi G, Nakanishi K, Kamiguchi K, Torigoe T, Sato N. 2011. Tumor‐produced secreted form of binding of immunoglobulin protein elicits antigen‐specific tumor immunity. J Immunol 186:4325–4330. [DOI] [PubMed] [Google Scholar]
  77. Tarr JM, Winyard PG, Ryan B, Harries LW, Haigh R, Viner N, Eggleton P. 2010. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)‐mediated apoptosis of T cells. Arthritis Rheum 62:2919–2929. [DOI] [PubMed] [Google Scholar]
  78. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel‐Duby R, Olson EN, Anderson ME, Tabas I. 2009. Calcium/calmodulin‐dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 119:2925–2941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Tobisawa S, Hozumi Y, Arawaka S, Koyama S, Wada M, Nagai M, Aoki M, Itoyama Y, Goto K, Kato T. 2003a. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild‐type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem Biophys Res Commun 303:496–503. [DOI] [PubMed] [Google Scholar]
  80. Tobisawa S, Hozumi Y, Arawaka S, Koyama S, Wada M, Nagai M, Aoki M, Itoyama Y, Goto K, Kato T. 2003b. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild‐type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem Biophys Res Commun 303:496–503. [DOI] [PubMed] [Google Scholar]
  81. Udono H, Levey DL, Srivastava PK. 1994. Cellular‐requirements for tumor‐specific immunity elicited by heat‐shock proteins—Tumor rejection antigen‐GP96 primes CD8+ t‐cells in‐vivo. Proc Natl Acad Sci USA 91:3077–3081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. 2006. Chromogranin‐mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108–118. [DOI] [PubMed] [Google Scholar]
  83. van 't Wout EF, van Schadewijk A, van Boxtel R, Dalton LE, Clarke HJ, Tommassen J, Marciniak SJ, Hiemstra PS. 2015. Virulence factors of pseudomonas aeruginosa induce both the unfolded protein and integrated stress responses in airway epithelial cells. PLoS Pathog 11:e1004946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Walter P, Ron D. 2011. The unfolded protein response: From stress pathway to homeostatic regulation. Science 334:1081–1086. [DOI] [PubMed] [Google Scholar]
  85. Wang JJ, Cheng QY, Wang X, Zu BB, Xu JH, Xu YH, Zuo XB, Shen YJ, Wang J, Shen YX. 2014. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus. Am J Med Sci 348:465–473. [DOI] [PubMed] [Google Scholar]
  86. Wang Y, Vera L, Fischer WH, Montminy M. 2009. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 460:534–537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Watanabe K, Ohira H, Orikasa H, Saito K, Kanno K, Shioya Y, Obara K, Sato Y. 2006. Anti‐calreticulin antibodies in patients with inflammatory bowel disease. Fukushima J Med Sci 52:1–11. [DOI] [PubMed] [Google Scholar]
  88. Watkin LB, Jessen B, Wiszniewski W, Vecel TJ, Jan M, Sha Y, Thamsen M, Santos‐Cortez RLP, Lee K, Gambint T, Forbes LR, Law CS, Stray‐Pedersenzt A, Cheng MH, Mace EM, Anderson MS, Liu D, Tang LF, Nicholas SK, Nahmod K, Makedonas G, Canter DL, Kwok P‐Y, Hicks J, Jones KD, Penney S, Jhangiani SN, Rosenblum MD, Dell SD, Waterfield MR, Papa FR, Muzny DM, Zaitlen N, Leal SM, Gonzaga‐Jaureguit C, Boerwinkle E, Eissa NT, Gibbs RA, Lupski JR, Orange JS, Shum AK, Baylor‐Hopkins Ctr Mendelian G. 2015. COPA mutations impair ER‐Golgi transport and cause hereditary autoimmune‐mediated lung disease and arthritis. Nat Genet 47:654–660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Watowich SS, Morimoto RI, Lamb RA. 1991. Flux of the paramyxovirus hemagglutinin‐neuraminidase glycoprotein through the endoplasmic‐reticulum activates transcription of the GRP78‐BIP gene. J Virol 65:3590–3597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Weber CK, Haslbeck M, Englbrecht M, Sehnert B, Mielenz D, Graef D, Distler JH, Mueller RB, Burkhardt H, Schett G, Voll RE, Furnrohr BG. 2010. Antibodies to the endoplasmic reticulum‐resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus. Rheumatology 49:2255–2263. [DOI] [PubMed] [Google Scholar]
  91. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, West S, Williamson KS, Zemlan F, Hensley K. 2004. The arachidonic acid 5‐lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A‐SOD1 transgenic mice. J Neurochem 91:133–143. [DOI] [PubMed] [Google Scholar]
  92. Williams LM. 2012. Hypothalamic dysfunction in obesity. Proc Nutr Soc 71:521–533. [DOI] [PubMed] [Google Scholar]
  93. Wootz H, Hansson I, Korhonen L, Napankangas U, Lindholm D. 2004. Caspase‐12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. Biochem Biophys Res Commun 322:281–286. [DOI] [PubMed] [Google Scholar]
  94. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. 2001. Marked increase in cyclooxygenase‐2 in ALS spinal cord—Implications for therapy. Neurology 57:952–956. [DOI] [PubMed] [Google Scholar]
  95. Ye RS, Holland WL, Gordillo R, Wang M, Wang QA, Shao ML, Morley TS, Gupta RK, Stahl A, Scherer PE. 2014. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes beta‐cell regeneration. eLife 3:e03851. doi: 10.7554/eLife.03851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, Banati RR, Anand P. 2006. COX‐2, CB2 and P2×7‐immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12. doi: 10.1186/1471-2377-6-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Zeng LX, Tao J, Liu HL, Tan SW, Yang YD, Peng XJ, Liu ZH, Jiang J, Wu B. 2015. Beta‐Arrestin2 encourages inflammation‐induced epithelial apoptosis through ER stress/PUMA in colitis. Mucosal Immunol 8:683–695. [DOI] [PubMed] [Google Scholar]
  98. Zha X, Yue Y, Dong N, Xiong S. 2015. Endoplasmic reticulum stress aggravates viral myocarditis by raising inflammation through the IRE1‐associated NF‐kappaB pathway. Can J Cardiol pii: S0828‐282X(15)00178‐6. doi: 10.1016/j.cjca.2015.03.003. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  99. Zhang W, Wang TG, Pei Z, Miller DS, Wu XF, Block ML, Wilson B, Zhang WQ, Zhou Y, Hong JS, Zhang J. 2005. Aggregated alpha‐synuclein activates microglia: A process leading to disease progression in Parkinson's disease. FASEB J 19:533–542. [DOI] [PubMed] [Google Scholar]
  100. Zhou Y, Rui L. 2013. Leptin signaling and leptin resistance. Front Med 7:207–222. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular Physiology are provided here courtesy of Wiley

RESOURCES